NEUROCRINE BIOSCIENCES INC - NOTE 2.250% 5/1

CUSIP: 64125CAD1

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Debt / NOTE 2.250% 5/1
Market price (% of par)
170.66%
Total 13F principal
$485,409,450
Principal change
+$12,372,450
Total reported market value
$829,851,783
Number of holders
48
Value change
+$27,955,520
Number of buys
23
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 64125CAD1?
CUSIP 64125CAD1 identifies 64125CAD1 - NEUROCRINE BIOSCIENCES INC - NOTE 2.250% 5/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEUROCRINE BIOSCIENCES INC - NOTE 2.250% 5/1 as of Q3 2018

As of 30 Sep 2018, NEUROCRINE BIOSCIENCES INC - NOTE 2.250% 5/1 was held by 48 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $485,409,450 in principal (par value) of the bond. The largest 10 bondholders included Allianz Asset Management GmbH, FRANKLIN RESOURCES INC, Invesco Ltd., UBS ASSET MANAGEMENT AMERICAS INC, WELLS FARGO & COMPANY/MN, CALAMOS ADVISORS LLC, MACKAY SHIELDS LLC, DEUTSCHE BANK AG\, BANK OF AMERICA CORP /DE/, and STATE STREET CORP. This page lists 48 institutional bondholders reporting positions for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.